Capricor Therapeutics Financial Overview
Capricor Therapeutics's market cap is currently $1.51B. The company's EPS TTM is $-0.54; its P/E ratio is -16.40; Capricor Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
